10/08/2014 - 11:33am

Pending legislation in the Pennsylvania state legislature is raising the eyebrows of several industry members, including the National Community Pharmacists Association, which stated that the legislation in its current form would "severely limit access to more affordable medications, vastly increase overall healthcare costs to Pennsylvania businesses and citizens and add cumbersome reporting requirements on healthcare providers."

10/07/2014 - 10:52am

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

10/07/2014 - 9:29am

The Network for Excellence in Health Innovation on Monday announced the recipients of its 2014 Innovators in Health award, which recognizes individuals whose work reflects the spirit of NEHI and embraces the mission of improving the quality of health care and reducing costs for patients and their families. 

10/06/2014 - 3:36pm

In honor of the 75th anniversary of the company’s founding, Dollar General chairman and CEO Rick Dreiling and other senior leaders rang the opening bell Monday morning at the New York Stock Exchange.

10/06/2014 - 9:13am

Healthcare Distribution Management Association released a statement in support of the FDA’s “Know Your Source” campaign.

10/06/2014 - 8:46am

The Council for Responsible Nutrition on Monday urged the U.S. District Court in New Jersey to hold the Federal Trade Commission to the flexible “competent and reliable scientific evidence” standard for review of dietary supplement advertising.

10/01/2014 - 10:37am

California Governor Jerry Brown on Tuesday signed legislation for the nation's first statewide ban on single-use plastic bags at supermarkets, drug stores and select other retail outlets.

09/30/2014 - 11:55am

Salix Pharmaceuticals and Progenics Pharmaceuticals announced that the Food and Drug Administration approved Relistor (methylnaltrexone bromide) subcutaneous injection in 12-mg dosage strength to treat constipation in patients taking opioids for chronic, non-cancer pain. 

09/26/2014 - 1:25pm

Boehringer Ingelheim Pharmaceuticals announced that the Food and Drug Administration approved Spiriva Respimat (tiotropium bromide) inhalation spray as a treatment for bronchospasm associated with chronic obstructive pulmonary disease.